# Cocrystal Pharma (COCP) — Earnings

COCP · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/cocp/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.20 |
| EPS estimate | −$0.23 |
| EPS surprise | +13.04% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 14, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1412486/000164117225023728/form10-q.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 14, 2025 | −$0.23 | −$0.20 | 13.04% | — | — |
| Q1 2025 | May 15, 2025 | −$0.51 | −$0.23 | 54.46% | — | — |
| Q4 2024 | Mar 31, 2025 | −$0.53 | −$0.31 | 41.51% | — | — |
| Q3 2024 | Nov 13, 2024 | −$0.57 | −$0.49 | 14.04% | — | — |
| Q2 2024 | Aug 14, 2024 | −$0.48 | −$0.53 | -11.18% | — | — |
| Q1 2024 | May 13, 2024 | −$0.54 | −$0.39 | 27.78% | — | — |
| Q4 2023 | Mar 28, 2024 | −$0.60 | −$0.32 | 46.37% | — | — |
| Q3 2023 | Nov 13, 2023 | −$0.53 | −$0.41 | 22.64% | — | — |
| Q2 2023 | Aug 14, 2023 | −$0.58 | −$0.50 | 13.79% | $266,667.00 | — |
| Q1 2023 | May 15, 2023 | −$0.60 | −$0.64 | -6.67% | $166,667.00 | — |
| Q4 2022 | Mar 29, 2023 | −$0.73 | −$0.59 | 18.81% | — | — |
| Q3 2022 | Nov 14, 2022 | −$0.49 | −$0.70 | -43.83% | $83,333.00 | — |
| Q2 2022 | Aug 15, 2022 | −$0.52 | −$3.00 | -476.92% | $83,333.00 | — |
| Q1 2022 | May 11, 2022 | −$0.42 | −$0.48 | -14.29% | $625,000.00 | — |
| Q4 2021 | Mar 23, 2022 | −$0.48 | −$0.48 | 0.00% | — | — |
| Q3 2021 | Nov 15, 2021 | −$0.48 | −$0.48 | 0.00% | $275,000.00 | — |
| Q2 2021 | Aug 16, 2021 | −$0.42 | −$0.48 | -14.29% | $275,000.00 | — |
| Q1 2021 | May 17, 2021 | −$0.54 | −$0.48 | 11.11% | $550,000.00 | — |
| Q4 2020 | Mar 17, 2021 | −$0.48 | −$0.24 | 50.00% | $580,000.00 | $515,000.00 |

## Frequently Asked Questions

### When did Cocrystal Pharma (COCP) last report earnings?

Cocrystal Pharma last reported on Aug 14, 2025, covering fiscal Q2 2025.

### Did COCP beat earnings estimates?

Yes. Cocrystal Pharma reported EPS of −$0.20 for Q2 2025 against a −$0.23 estimate — a 13.04% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).